Connection

Alfred Kim to Pandemics

This is a "connection" page, showing publications Alfred Kim has written about Pandemics.
Connection Strength

0.057
  1. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821.
    View in: PubMed
    Score: 0.029
  2. Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease. Best Pract Res Clin Rheumatol. 2021 03; 35(1):101664.
    View in: PubMed
    Score: 0.008
  3. The complement system in COVID-19: friend and foe? JCI Insight. 2020 08 06; 5(15).
    View in: PubMed
    Score: 0.007
  4. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Ann Intern Med. 2020 06 02; 172(11):754-755.
    View in: PubMed
    Score: 0.007
  5. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
    View in: PubMed
    Score: 0.002
  6. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. 2020 10; 79(10):1386-1388.
    View in: PubMed
    Score: 0.002
  7. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.